Filing Details

Accession Number:
0001209191-18-004229
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-18 16:04:26
Reporting Period:
2018-01-16
Accepted Time:
2018-01-18 16:04:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1488613 Foundation Medicine Inc. FMI Services-Medical Laboratories (8071) 271316416
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1584999 A. Vincent Miller 150 Second Street
C/O Foundation Medicine, Inc.
Cambridge MA 02141
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-01-16 3,813 $65.26 93,322 No 4 S Direct
Common Stock Acquisiton 2018-01-16 5,408 $0.84 98,730 No 4 M Direct
Common Stock Disposition 2018-01-16 5,408 $65.26 93,322 No 4 S Direct
Common Stock Acquisiton 2018-01-17 5,534 $0.84 98,856 No 4 M Direct
Common Stock Disposition 2018-01-17 5,534 $65.39 93,322 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-01-16 5,408 $0.00 5,408 $0.84
Common Stock Stock Option (right to buy) Disposition 2018-01-17 5,534 $0.00 5,534 $0.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,534 2022-01-10 No 4 M Direct
0 2022-01-10 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017.
  2. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.15 to $68.75, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  3. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.00 to $66.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  4. The option was granted on January 10, 2012 and vested in equal quarterly installments beginning on December 31, 2012 until fully vested on April 8, 2016.